Fig. S8.
Chronic application of PMB-TBOA by Elvax did not alter the expression pattern of glial glutamate transporters. Immunofluorescence for GLAST (A and B) and GLT-1 (C and D) in the cerebellum of vehicle-treated (A and C) and PMB-TBOA–treated (5 μM) (B and D) wild-type mice. Micrographs were taken from zone III (shown by red dotted lines in Fig. 6 A and C), an adjacent portion deep to Elvax implant. (Scale bars, 20 μm.)